Refractory status epilepticus in children with and without prior epilepsy or status epilepticus

Iván Sánchez Fernández1, Michele C Jackson1, Nicholas S Abend1

  • 1From the Division of Epilepsy and Clinical Neurophysiology, Department of Neurology (I.S.F., M.C.J., M.G.L., K.K., T.L.), and Division of Critical Care, Departments of Neurology, Anesthesiology, Perioperative and Pain Medicine (R.C.T.), Boston Children's Hospital, Harvard Medical School, MA; Department of Child Neurology (I.S.F.), Hospital Sant Joan de Déu, Universidad de Barcelona, Spain; Division of Neurology (N.S.A., A.A.T.), The Children's Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania; Cincinnati Children's Hospital Medical Center (R.A., T.A.G., K.P.), University of Cincinnati, OH; Department of Neurology and Pediatrics (J.N.B., H.P.G.), The University of Virginia Health System, Charlottesville; Department of Epilepsy, Neurophysiology, and Critical Care Neurology (J.L.C., W.D.G.), Children's National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC; Departments of Pediatrics and Neurology (K.E.C.), Children's Hospital Colorado, University of Colorado School of Medicine, Aurora; Universidad Austral de Chile (M.G.L.), Valdivia, Chile; Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program (J.L.G., M.S.W.), Northwestern University Feinberg School of Medicine, Chicago, IL; Division of Pediatric Neurology (A.H., M.A.M.), Duke University Medical Center, Duke University, Durham, NC; Division of Child Neurology (T.L.M., J.R.), Department of Neurology, Columbia University Medical Center, Columbia University, New York, NY; Section of Neurology and Developmental Neuroscience (A.W.), Department of Pediatrics, Baylor College of Medicine, Houston, TX; Barrows Neurological Institute (K.W.), Phoenix Children's Hospital; Department of Pediatrics (K.W.), University of Arizona School of Medicine, Tucson; and Department of Neurology (K.W.), Mayo Clinic, Scottsdale, AZ.

Neurology
|December 25, 2016
PubMed

Insights

Children with refractory convulsive status epilepticus (rSE) do not receive faster treatment with a prior epilepsy diagnosis. However, a history of status epilepticus (SE) is linked to quicker initial medication for rSE.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Critical Care Medicine

Background:

  • Refractory convulsive status epilepticus (rSE) poses significant challenges in pediatric care.
  • Understanding factors influencing rSE management and outcomes is crucial for improving patient care.

Purpose of the Study:

  • To compare the management and outcomes of rSE in children based on prior epilepsy diagnosis and history of status epilepticus (SE).

Main Methods:

  • A prospective observational study included 189 pediatric patients (1 month-21 years) with rSE from June 2011 to May 2016.
  • Data collected included prior epilepsy diagnosis, history of SE, and timing of antiepileptic drug (AED) administration.

Main Results:

  • While a prior epilepsy diagnosis did not affect the time to first benzodiazepine (BZD), it was associated with a delayed first non-BZD AED and less frequent use of continuous infusions.
  • Patients with a history of SE received their first BZD more quickly compared to those without a history of SE.
  • Differences in treatment timing were primarily observed in patients with out-of-hospital rSE onset.

Conclusions:

  • A prior diagnosis of epilepsy does not appear to expedite rSE treatment in children.
  • A history of SE is associated with more prompt administration of initial abortive medications for rSE.
  • These findings highlight the importance of considering prior SE history in managing pediatric rSE.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595